Ascensia Diabetes Care launches new cloud-based diabetes administration and analytics platform

0
480

The Swiss company Ascensia Diabetes Care, manufacturer of connected glucose measuring devices, presented its new platform for diabetes management and analysis called GlucoContro.online this morning.

The tool can work with the company’s existing Contour glucose meters and collect data directly from the Contour Diabetes app or the Contour cloud. The new platform is cloud-based and allows users to open it in their browsers. Users can then share their data with clinicians and care teams.

Patients with no blood glucose meters connected can also use the technology through a cable, which the company claims requires a one-step installation. After downloading the information, these patients can also access their data and share it with care teams.

The data contained on the platform ranges from blood sugar measurements to insulin dosing and food activities.

“Simplifying and improving the lives of people with diabetes through innovative solutions is at the heart of everything we do at Ascensia, and the GlucoContro.online platform is a step in that direction,” said Rob Schumm, president of Ascensia Diabetes Care, in a statement .

“It was born out of clearly defined, unmet needs of both health professionals and people with diabetes. From simple installation to the features that allow quick and easy access and analysis of data, it offers a valuable one and easy way to share and use blood glucose and other data to help doctors and people optimize their diabetes management. “

WHY IT IS IMPORTANT

Diabetes is a common disease worldwide. According to the World Health Organization, 8.5% of adults aged 18 and over had diabetes as of 2014. The condition caused 1.5 million deaths in 2019.

In the United States alone, 34.2 million adults have diabetes, according to the CDC. The condition can be managed. Innovators around the world want to help reduce the administrative burden with technology-based products.

THE BIGGER TREND

Ascensia Diabetes Care was founded in 2016 when Panasonic Healthcare Holdings acquired Bayer Diabetes Care. Later that year, the company received FDA approval for its Contour Next Link blood glucose meter, which could wirelessly send data to Medtronic’s MiniMed 630G insulin pump.

Later that year, the company launched Contour Next One, expanding its customers beyond Medtronic users and connecting to the Contour Diabetes app via Bluetooth.